Premarket Mover: Chinook Therapeutics Inc (KDNY) Down 5.89%

Wednesday, May 25, 2022 06:45 AM | InvestorsObserver Analysts

Mentioned in this article

Premarket Mover: Chinook Therapeutics Inc (KDNY) Down 5.89%

Chinook Therapeutics Inc (KDNY) has fallen Wednesday morning, with the stock falling -5.89% in pre-market trading to 14.22. KDNY's short-term technical score of 90 indicates that the stock has traded more bullishly over the last month than 90% of stocks on the market. In the Biotechnology industry, which ranks 133 out of 146 industries, KDNY ranks higher than 96% of stocks. Chinook Therapeutics Inc has risen 1.68% over the past month, closing at $14.46 on April 27. During this period of time, the stock fell as low as $12.59 and as high as $16.87. KDNY has an average analyst recommendation of Strong Buy. The company has an average price target of $31.50.

KDNY has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on KDNY!

See Full KDNY Report

Chinook Therapeutics Inc has a Long-Term Technical rank of 88. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 12% of the market scoring higher. In the Biotechnology industry which is number 139 by this metric, KDNY ranks better than 139% of stocks.

Important Dates for Investors in KDNY:

-Chinook Therapeutics Inc is set to release earnings on 8/10/2022. Over the last 12 months, the company has reported EPS of $-1.92. -We do not have a set dividend date for Chinook Therapeutics Inc at this time. Click Here To Get The Full Report on Chinook Therapeutics Inc (KDNY)